Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Leopold

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Southern Med Review|March 28, 2013
Impact of external price referencing on medicine prices - a price comparison among 14 European countriesChristine Leopold, Aukje Katja Mantel-Teeuwisse, Leonhard Seyfang, et al.
International Journal for Equity in Health|July 27, 2014
Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analysesChristine Leopold, Fang Zhang, Aukje K Mantel-Teeuwisse, et al.
Health Policy (Amsterdam, Netherlands)|September 25, 2013
Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countriesChristine Leopold, Aukje Katja Mantel-Teeuwisse, Sabine Vogler, et al.
Acta Oncologica (Stockholm, Sweden)|January 14, 2026
Stakeholders' experiences with a clinician-led access programme linking evidence generation and reimbursement for precision cancer treatments: the drug access protocol in the NetherlandsChristine Leopold, Atse H Huisman, Kevin J G M Vlaar, et al.
Breast Cancer Research and Treatment|June 26, 2016
Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancerChristine Leopold, Anita K Wagner, Fang Zhang, et al.
Breast Cancer Research and Treatment|June 2, 2018
Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plansChristine Leopold, Anita K Wagner, Fang Zhang, et al.
British Journal of Clinical Pharmacology|April 30, 2026
Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBaseComfort Kunak Ogar, Malede Mequanent Sisay, Leonardo Roque-Pereira, et al.
Orphanet Journal of Rare Diseases|October 28, 2025
Drivers of managed entry agreements to reduce reimbursement challenges of orphan medicinal products: the development of a matrixMarcelien H E Callenbach, Sibren van den Berg, Alisa Hulsbosch, et al.
Bulletin of the World Health Organization|November 8, 2014
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countriesChristine Leopold, Aukje K Mantel-Teeuwisse, Sabine Vogler, et al.
JAMIA Open|April 30, 2026
Text mining methods for automated data extraction from health technology assessment reports of medicines using classical natural language processing and generative artificial intelligenceJan-Willem Versteeg, Marie L De Bruin, Maarten Schermer, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Southern Med Review|March 28, 2013
Impact of external price referencing on medicine prices - a price comparison among 14 European countriesChristine Leopold, Aukje Katja Mantel-Teeuwisse, Leonhard Seyfang, et al.
International Journal for Equity in Health|July 27, 2014
Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analysesChristine Leopold, Fang Zhang, Aukje K Mantel-Teeuwisse, et al.
Health Policy (Amsterdam, Netherlands)|September 25, 2013
Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countriesChristine Leopold, Aukje Katja Mantel-Teeuwisse, Sabine Vogler, et al.
Acta Oncologica (Stockholm, Sweden)|January 14, 2026
Stakeholders' experiences with a clinician-led access programme linking evidence generation and reimbursement for precision cancer treatments: the drug access protocol in the NetherlandsChristine Leopold, Atse H Huisman, Kevin J G M Vlaar, et al.
Breast Cancer Research and Treatment|June 26, 2016
Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancerChristine Leopold, Anita K Wagner, Fang Zhang, et al.
Breast Cancer Research and Treatment|June 2, 2018
Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plansChristine Leopold, Anita K Wagner, Fang Zhang, et al.
British Journal of Clinical Pharmacology|April 30, 2026
Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBaseComfort Kunak Ogar, Malede Mequanent Sisay, Leonardo Roque-Pereira, et al.
Orphanet Journal of Rare Diseases|October 28, 2025
Drivers of managed entry agreements to reduce reimbursement challenges of orphan medicinal products: the development of a matrixMarcelien H E Callenbach, Sibren van den Berg, Alisa Hulsbosch, et al.
Bulletin of the World Health Organization|November 8, 2014
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countriesChristine Leopold, Aukje K Mantel-Teeuwisse, Sabine Vogler, et al.
JAMIA Open|April 30, 2026
Text mining methods for automated data extraction from health technology assessment reports of medicines using classical natural language processing and generative artificial intelligenceJan-Willem Versteeg, Marie L De Bruin, Maarten Schermer, et al.
Pageof 4